Skip to main content

Revolution Medicines, Inc. (RVMD) Stock

Revolution Medicines, Inc. Stock Details, Movements and Public Alerts

Stock Details

Revolution Medicines, Inc. (RVMD), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NMS.Currently, the stock is trading at $205.00. Over the past 52 weeks, it has ranged between $42.18 and $224.31. This places the current price at 91.4% of its 52-week high and 386.0% above its 52-week low. Recent trading volume was recorded at 1,268,755. The 14-day Relative Strength Index (RSI) stands at 49.77, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $198.86 by 3.09%. Similarly, it is above its 200-day moving average of $138.06 by 48.49%. The MACD histogram is -1.73, indicating bearish momentum (MACD Line: 1.59, Signal Line: 3.32). There is currently 1 active alert set for RVMD by users.

52-Week Range

$224.31 - $42.18

-8.61% from high · +386.01% from low

Avg Daily Volume

1,713,241

20-day average

100-day avg: 2,454,589

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-34.41

Price to Book

16.84

EV/EBITDA

-25.44

EPS (TTM)

-$8.86

Beta

1.41

Similar volatility to market

Q:How is RVMD valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is RVMD's risk profile compared to the market?
With a beta of 1.41, Revolution Medicines, Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 16.84 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-1,618,188,032

Return on Equity

-79.09%

Return on Assets

-30.12%

Q:How profitable and efficient is RVMD's business model?
Profitability metrics are not available for this stock.
Q:What are RVMD's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$43.9B

Shares Outstanding

214.34M

Book Value/Share

$12.17

Asset Type

EQUITY

Q:What is RVMD's market capitalization and position?
Revolution Medicines, Inc. has a market capitalization of $43.9B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 214.34M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does RVMD's price compare to its book value?
Revolution Medicines, Inc.'s book value per share is $12.17, while the current stock price is $205.00, resulting in a price-to-book (P/B) ratio of 16.85. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$251.21

22.54% upside potential

Analyst Recommendations

Strong Buy

4

Buy

17

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for RVMD?
21 analysts cover RVMD with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $251.21 implies 22.5% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on RVMD?
Current analyst recommendations:4 Strong Buy, 17 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Sep 16, 2026, 02:04 AM

Technical Indicators

RSI (14-day)

49.77

Neutral

50-Day Moving Average

$198.86

3.09% above MA-50

200-Day Moving Average

$138.06

48.49% above MA-200

MACD Line

1.59

MACD Signal

3.32

MACD Histogram

-1.73

Bearish

Q:What does RVMD's RSI value tell investors?
The RSI (Relative Strength Index) for RVMD is currently 49.77, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret RVMD's MACD and moving average crossovers?
MACD analysis shows the MACD line at 1.59 below the signal line at 3.32, with histogram at -1.73. This bearish crossover indicates downward pressure. The wide histogram confirms strong momentum. The 50-day MA ($198.86) is above the 200-day MA ($138.06), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Sep 16, 2026, 01:22 AM

Active Alerts

Alert Condition
Earnings Announcement
Threshold
3 days
Created
Jan 27, 2026, 04:22 PM

Stay Ahead of the Market with Revolution Medicines, Inc. Alerts

Set up price alerts for Revolution Medicines, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.